Inventor
URMANN MATTHIAS
US32 patents
⚠️ This page may combine multiple inventors who share the name “URMANN MATTHIAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS
10 patentsUS7709481B2May 4, 2010
Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticals
SANOFI AVENTIS4 citations61
US7655679B2Feb 2, 2010
Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions
SANOFI AVENTIS2 citations61
US7772257B2Aug 10, 2010
Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use
SANOFI AVENTIS0 citations52
US7612104B2Nov 3, 2009
Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use
SANOFI AVENTIS0 citations52
US7851493B2Dec 14, 2010
Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS0 citations51
US7834030B2Nov 16, 2010
Phenyl-[1,2,4]-oxadiazol-5-one derivatives, pharmaceutical compositions and therapeutic use thereof
SANOFI AVENTIS0 citations51
US8026375B2Sep 27, 2011
Transition metal catalyzed synthesis of N-aminoindoles
SANOFI AVENTIS2 citations50
US7910612B2Mar 22, 2011
4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use
SANOFI AVENTIS0 citations41
US7858647B2Dec 28, 2010
N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use
SANOFI AVENTIS0 citations41
US7683181B2Mar 23, 2010
Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof
SANOFI AVENTIS0 citations41
SANOFI AVENTIS DEUTSCHLAND
6 patentsUS7365088B2Apr 29, 2008
Indazole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND25 citations92
US7317027B2Jan 8, 2008
Azaindole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND26 citations92
US7465806B2Dec 16, 2008
Pyrrole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND18 citations84
US7449560B2Nov 11, 2008
Phosophoinositoglycan binding proteins
SANOFI AVENTIS DEUTSCHLAND2 citations63
US7049416B2May 23, 2006
Phosophoinositoglycan binding proteins
SANOFI AVENTIS DEUTSCHLAND2 citations63
US7741341B2Jun 22, 2010
Benzimidazole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND0 citations42
KEIL STEFANIE
4 patentsUS8173674B2May 8, 2012
Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
KEIL STEFANIE25 citations91
US8716317B2May 6, 2014
Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
KEIL STEFANIE2 citations58
US8946212B2Feb 3, 2015
Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
KEIL STEFANIE0 citations51
US8329725B2Dec 11, 2012
Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
KEIL STEFANIE0 citations48
AVENTIS PHARMA INC
4 patentsUS7772252B2Aug 10, 2010
Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
AVENTIS PHARMA INC22 citations91
US7186724B2Mar 6, 2007
Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
AVENTIS PHARMA INC4 citations59
US7550469B2Jun 23, 2009
Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
AVENTIS PHARMA INC3 citations56
US7521445B2Apr 21, 2009
Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
AVENTIS PHARMA INC0 citations50